Verastem Oncology
Developing cancer treatments
- B2B
About Verastem Oncology
A late-stage biopharmaceutical company dedicated to developing and commercializing new medicines for cancer patients by inhibiting critical signaling pathways
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- needham, massachusetts, United States
- Founded
- 2010
- Revenue
- $30.9MFY2025, publicly reported
- Website
- verastem.com
Verastem Oncology at a glance
Verastem Oncology is a B2B company in the Biotechnology Research industry, headquartered in needham, massachusetts, United States.
Verastem Oncology was founded in 2010.
Verastem Oncology has 51–250 employees.
Verastem Oncology's revenue is $30.9M (FY2025, publicly reported).
Frequently asked questions about Verastem Oncology
What is Verastem Oncology's revenue?
Verastem Oncology's revenue is $30.9M (FY2025, publicly reported).
How many employees does Verastem Oncology have?
Verastem Oncology has 51–250 employees.
Where is Verastem Oncology headquartered?
Verastem Oncology is headquartered in needham, massachusetts, United States.
Selling to companies like Verastem Oncology?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies